Education
About Us
Working with TipRanks
Follow Us
Sanjiv Patel Insider Profile
4 Followers
Sanjiv Patel, President & CEO, Director at Relay Therapeutics, holds 1.55M shares in Relay Therapeutics (Ticker: RLAY), holds ― shares in Prothena (Ticker: PRTA).
Sanjiv Patel Relay Therapeutics (RLAY)President & CEO, Director
Relay Therapeutics (RLAY)
President & CEO, Director
Ranked #101,063 out of 105,518 Corporate Insiders
Profitable Transactions
1 out of 6 Profitable Transactions
Average Return
-66.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sanjiv Patel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sanjiv Patel
Sanjiv Patel's Trading History
Relay Therapeutics
Jan 07, 2026
President & CEO, Director
Uninformative Buy
2.97K
$12.07M
Prothena
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Sanjiv Patel's performance on stock
You May Also Like
Sanjiv Patel insider profile FAQ
What is the percentage of profitable transactions made by Sanjiv Patel?
The percentage of profitable transactions made by Sanjiv Patel is 17%.
What is the average return per transaction made by Sanjiv Patel?
The average return per transaction made by Sanjiv Patel is -66.30%.
What stocks does Sanjiv Patel hold?
Sanjiv Patel holds: RLAY, PRTA stocks.
What was Sanjiv Patel’s latest transaction?
Sanjiv Patel latest transaction was an Uninformative Buy of $2.97K.
What was Sanjiv Patel's most profitable transaction?
Sanjiv Patel’s most profitable transaction was an Informative Sell of RLAY stock on January 7, 2026. The return on the trade was 2.20%.
What is Sanjiv Patel's role in Relay Therapeutics?
Sanjiv Patel's role in Relay Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.